Invention Grant
- Patent Title: Active principle for mitigating undesired medical conditions
- Patent Title (中): 缓解不良医疗状况的主动原则
-
Application No.: US13982492Application Date: 2012-01-25
-
Publication No.: US09302013B2Publication Date: 2016-04-05
- Inventor: Tim Bowden , Kristoffer Bergman , Thomas Engstrand , Lennart Soderberg
- Applicant: Tim Bowden , Kristoffer Bergman , Thomas Engstrand , Lennart Soderberg
- Applicant Address: SE Uppsala
- Assignee: TERMIRA AB
- Current Assignee: TERMIRA AB
- Current Assignee Address: SE Uppsala
- Agency: Young & Thompson
- Priority: SE1100066 20110131
- International Application: PCT/SE2012/000006 WO 20120125
- International Announcement: WO2012/105887 WO 20120809
- Main IPC: A61K47/48
- IPC: A61K47/48 ; A61K31/765 ; A61K31/785

Abstract:
A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic center complying with the formula X1(—R″—)(—R′)mHn where: a) X1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) —R″— is a bivalent organic group providing attachment to the carrier via one of its free valences and to X1 at the other free valence; and d) R′— is a monovalent organic group attached to the X1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.
Public/Granted literature
- US20130302268A1 ACTIVE PRINCIPLE FOR MITIGATING UNDESIRED MEDICAL CONDITIONS Public/Granted day:2013-11-14
Information query